BioSpace News Archive

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the appointment of Dr. Michele Pedrocchi to its Strategic Advisory Board.

AlzeCure Pharma AB announced that the company arranges a digital Capital Markets Day on 18 January 2022 at 13:00-14:30 CET, with Professor Bengt Winblad at Karolinska Institutet, Stockholm, invited as guest presenter.

Manufactures in the market are producing improved version with life span ranging from six months to one year.

Novavax, Inc. and SK bioscience, Co. Limited announced that South Korea’s Ministry of Food and Drug Safety has approved a Biologics License Application from SK bioscience for Nuvaxovid™ COVID-19 Vaccine for active immunization in individuals 18 years of age and older for the prevention of COVID-19 caused by SARS-CoV-2.

Glytec, the only provider of cloud-based insulin management software across the continuum of care, announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics.

Targovax ASA announces that Innovation Norway has awarded Targovax an NOK 8.2m grant to accelerate product development activities related to the company’s TG mutant RAS vaccine program and planned clinical trials.

Quest Diagnostics Incorporated announced today preliminary financial results for the fourth quarter and full year 2021.

DALI Medical Devices today announced the first commercial implementation of its SAN-Light passive safety needle.

Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B74710126) describing the safety and immunogenicity of PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in the United States 65 years of age or older when administered at the same time as the Pfizer-BioNTech COVID-19 Vaccine or when each vaccine was given with placebo.

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 40th Annual J.P. Morgan Healthcare Conference,